Through
5/7
Perelman School of Medicine
A novel technique to form human artificial chromosomes
A novel technique to form human artificial chromosomes
Penn researchers say the new technique for making human artificial chromosomes from single, long constructs of designer DNA will allow for more efficient laboratory research.
‘Welcome to your future’: Penn celebrates Match Day 2024
‘Welcome to your future’: Penn celebrates Match Day 2024
On the third Friday of March, Perelman School of Medicine’s class of 2024 celebrated their future residencies.
What the brain reveals in nature’s subtle game of give and take
What the brain reveals in nature’s subtle game of give and take
Research led by Michael Platt uncovers the neural pathways for primate reciprocity, social support, and empathy.
A humanities pathway to pre-med
A humanities pathway to pre-med
Pre-med students majoring in English, theatre, history, and other humanities fields find satisfaction in tapping into multiple interests—and see benefits for a career in medicine.
2023 PIP/PEP winners: Where are they now?
2023 PIP/PEP winners: Where are they now?
Nearly a year after the winners of the President’s Innovation Prize (PIP) and President’s Engagement Prize (PEP) began their projects, the winners—now alumni—discuss their progress.
37th annual Women of Color Day at Penn
37th annual Women of Color Day at Penn
The annual Women of Color at Penn awards honored students, staff, faculty and community members for their research, leadership, and service.
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants
Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them.
Mapping pancreatic cancer to improve immunotherapy
Mapping pancreatic cancer to improve immunotherapy
Gregory L. Beatty, an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center, and his team focus on improving immunotherapy for pancreatic cancer.
‘Dual target’ cell therapy appears to shrink brain tumors
‘Dual target’ cell therapy appears to shrink brain tumors
Early Penn Medicine trial results show that targeting two tumor-associated proteins in patients with recurrent glioblastoma may be a promising step toward developing cell therapies for solid tumors.
Building a more diverse health care workforce across the Delaware Valley
Building a more diverse health care workforce across the Delaware Valley
Iris Reyes, who founded the Alliance of Minority Physicians in 2012, is working to expand the program to underrepresented students and professionals across the region.
In the News
Philadelphia Inquirer
Inside Penn’s transfer center
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Philadelphia Inquirer
Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →
Philadelphia Inquirer
Broad Street runners from Penn are racing with gyroscopes to study the Achilles tendon
Casey Jo Humbyrd and Josh Baxter of the Perelman School of Medicine and colleagues will track data from running the Broad Street Run to understand how a healthy Achilles tendon functions.
FULL STORY →
National Geographic
What is topical steroid withdrawal? If you have eczema, here’s what you should know
Bruce Brod of the Perelman School of Medicine says that prolonged or overuse of topical steroids can cause rosacea, skin thinning, stretch marks, and an extreme and debilitating withdrawal.
FULL STORY →
Fox 29 (Philadelphia)
Cannabis reclassification could be game-changer for U.S. drug policy
Michael Cirigliano of the Perelman School of Medicine says that marijuana deserves to be removed from the same category as LSD, heroin, and fentanyl.
FULL STORY →